Robotics designed to enable everyone to do what they couldn't do before
It all started with a question that a young engineer couldn’t get out of his head. At the École Polytechnique robotics club, Nicolas Simon saw a machine learning to walk and thought of his brother, who was in the process of losing that ability. If a robot can walk, why not build one that walks for him?
Wandercraft was founded in Paris in 2012 to address this need, and the solution took ten years of engineering to develop: a self-balancing exoskeleton, so that the wearer doesn’t have to balance it. In 2019, Atalante became the first self-balancing walking exoskeleton to receive CE marking in Europe.
Today, this same technology supports rehabilitation in more than 150 clinical and research centers, extends beyond rehabilitation centers into the home with Eve, and lies at the heart of Calvin, our family of humanoid robots designed for the heaviest industrial tasks. Three products, two markets, one conviction: robotics must enable everyone to do what they couldn’t do before.
The same self-balancing technology across three scales—from clinical exoskeletons to humanoids designed for factory use.
Our clinical exoskeleton, which enables patients undergoing rehabilitation to walk hands-free and without crutches.
Our personal exoskeleton, designed to be taken home from the rehabilitation center and used by the person wearing it as they walk around their home.
Our humanoid robot, designed for the heaviest and most repetitive tasks in industrial settings.
Fourteen years, three robots, and an idea that has never left us. Scroll to the right to follow it.
Nicolas Simon, Matthieu Masselin, and Jean-Louis Constanza founded Wandercraft in Paris—inspired by a brother and a son who were losing the ability to walk.
The world's first clinical trials conducted with our prototypes show that people with paraplegia can walk hands-free, without crutches.
The world's first self-balancing exoskeleton has been approved in Europe and is helping its first patients walk at a rehabilitation center.
Atalante received FDA approval for stroke rehabilitation, paving the way for U.S. clinics—and, the following year, for our operations in the United States.
At Paris 2024, our exoskeletons will carry the Olympic and Paralympic torches—with Thibault Simon, the brother who started it all, among the torchbearers.
Our self-balancing personal exoskeleton is entering the testing phase with people who have spinal cord injuries at the Bronx VA and Kessler.
Renault Group is taking a stake in our company and becoming our industrial partner, alongside a Series D funding round aimed at scaling up production globally.
Building on more than ten years of exoskeleton engineering, the first Calvin prototype took shape in 40 days. Calvin-40 was unveiled with the Renault Group as its first customer.
Calvin-40 is being deployed on the production line at the Renault plant in Douai, with a fleet of 350 robots set to be in operation by 2027.
Eve has become the first self-balancing personal exoskeleton approved for home use by people with spinal cord injuries.
More than 175 leading experts in AI, robotics, and industry, working out of our two headquarters in Paris and New York.
We don't just hire people. We're building a team of pioneers, curious minds, and people who love to solve problems—and who want to change the world, one step at a time.
Apply
Our Paris offices have their own walking center; there’s another one in New York, and more are opening across the United States. Users work out there every day—no one here has to guess who we’re working for.
Full-body control, embedded AI, certifiable safety, robots that carry people and robots that carry loads—and a production line waiting for a response.
Our internal Expert Track program allows engineers to deepen their expertise in a specific field rather than advance through management. Here, seniority is not measured by the number of people supervised.
Paris and New York, purposefully connected: annual events that bring the entire company together, and commitments to well-being that we put in writing.
Come help shape the next generation of medical and humanoid robotics, driven by AI and purpose.
